Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP0211022
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Production and application of novel diagnostic and therapeutic reagents using transgenic mice. The project will be a collaboration between the University of Queensland and PanBio Ltd. We intend to use humanized transgenic mice to produce fully human monoclonal antibodies. Fully human antibodies have great advantages over murine antibodies as diagnostics and therapeutics. These reagents will be used to 1)replace human sera , 2)replace antigens from infectious organisms in a range of diagnostic kits for animal and human infectious disease and 3) as therapeutic leads and 4)to discover vaccine leads. The project will allow production of diagnostic kits where this was previously not feasible or not economically viable (eg. uncommon and/or dangerous animal or human diseases) and will lead to development of novel infectious disease diagnostics and therapeutics.Funded Activity Details
Start Date: 2002
End Date: 12-2004
Funding Scheme: Linkage Projects
Funding Amount: $194,344.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Agricultural Biotechnology | Diagnostic Applications | Transgenesis | Infectious Agents
